Study finds some medications may interact with common anti-recurrent preterm birth medication
(Society for Maternal-Fetal Medicine) In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that prescription medications may affect the body's ability to metabolize 17-alpha-hydroxyprogesterone caproate, the only FDA approved medication for the prevention of recurrent preterm birth. (Source: EurekAlert! - Medicine and Health)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div

Wide Variation in PCI for 'Unclear Indications'Wide Variation in PCI for 'Unclear Indications'
The latest study on this subject has found that 17% of hospitals in a large US sample conducted at least one-fifth of their procedures in patients whose indications for the procedure were unclear. Heartwire (Source: Medscape Today Headlines)